Cargando…
Potential glioblastoma biomarkers identified by mass spectroscopy and iTRAQ labeling
Autores principales: | Feng, Ruili, Chen, Mingyu, Luo, Guanghong, Chen, Yanlu, Wang, Jiao, Xu, Jian, Xu, Ming, Zhong, Ping, Wen, Tieqiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363635/ https://www.ncbi.nlm.nih.gov/pubmed/37492715 http://dx.doi.org/10.1016/j.gendis.2022.11.010 |
Ejemplares similares
-
iTRAQ-based proteomic analysis of duck muscle related to lipid oxidation
por: Zhang, Muhan, et al.
Publicado: (2021) -
Dcf1 induces glioblastoma cells apoptosis by blocking autophagy
por: Luo, Guanghong, et al.
Publicado: (2021) -
A Proteomic Approach for Plasma Biomarker Discovery with iTRAQ Labelling and OFFGEL
Fractionation
por: Ernoult, Emilie, et al.
Publicado: (2010) -
Improved proteome coverage by using iTRAQ labelling and peptide OFFGEL fractionation
por: Ernoult, Emilie, et al.
Publicado: (2008) -
Metabolic Peculiarities of Paracoccidioides brasiliensis Dimorphism as Demonstrated by iTRAQ Labeling Proteomics
por: Araújo, Danielle Silva, et al.
Publicado: (2019)